Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S(DE:2TZ)
€2.26-0.02 (-1.74%)
DE:2TZ
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Revenue
€2.26
At close:-0.02 (-1.74%)
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (2TZ) Revenue
0 Followers
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Revenue
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S had a revenue of 963.16M in the quarter ending Sep 30, 2026, with 2.82%. This bring the company's revenue in the last twelve months to 4.66B, Decreased 1.08%. In the fiscal year ending Dec 31, 2025, Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S had annual revenue of 4.92B with -32.70% growth.
- Revenue (ttm)
- 4.66B
- Revenue Growth
- ―
- P/S Ratio
- 0.74
- Revenue/Employee
- EUR 1,264,097
- Employees
- 3,890
- Market Cap
- EUR 3.62B
Revenue Chart
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.92B | -2.39B | -32.70% |
| Dec 31, 2024 | 7.31B | -915.58M | -11.14% |
| Dec 31, 2023 | 8.22B | -26.94M | -0.33% |
| Dec 31, 2022 | 8.25B | 1.34B | 19.42% |
| Dec 31, 2021 | 6.91B | 303.89M | 4.60% |
| Dec 31, 2020 | 6.60B | -390.23M | -5.58% |
| Dec 31, 2019 | 6.99B | 635.26M | 9.99% |
| Dec 31, 2018 | 6.36B | 669.38M | 11.77% |
| Dec 31, 2017 | 5.69B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.